Ofer Sarig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ofer Sarig has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Eli Sprecher
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
25 shared publications - Liat Samuelov
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
14 shared publications - Janan Mohamad
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
8 shared publications - Kiril Malovitski
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
8 shared publications - Alon Peled
Division of Dermatology Tel Aviv Sourasky Medical Center Tel Aviv Israel
6 shared publications - Mor Pavlovsky
Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
6 shared publications
Latest Publications
- Open Access
- 13 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (11) , 3102-3111.e3
An ITGB4 variant modifies the severity of ITGA3-associated interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB)
- 13 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (11) , 3102-3111.e3
Open AccessAn ITGB4 variant modifies the severity of ITGA3-associated interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa (ILNEB)
- Open Access
- 19 November 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (6) , 1596-1604.e2
Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia
- 19 November 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (6) , 1596-1604.e2
Open AccessPathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia
- Open Access
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
HMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.
- 20 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
Open AccessHMCN1 variants aggravate epidermolysis bullosa simplex phenotype
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.
- 19 September 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (12) , 2806-2812
Dominant frontonasal dysplasia with ectodermal defects results from increased activity of ALX4
Frontonasal dysplasia (FND) refers to a group of rare developmental disorders characterized by abnormal morphology of the craniofacial region. We studied a family manifesting with clinical features typical for FND2 including neurobehavioral abnormalities, hypotrichosis, hypodontia, and facial dysmorphism. Whole‐exome sequencing analysis identified a novel heterozygous frameshift insertion in ALX4 (c.985_986insGTGC, p.Pro329Argfs*115), encoding aristaless homeobox 4. This and a previously reported dominant FND2‐causing variant are predicted to result in the formation of a similar abnormally elongated protein tail domain. Using a reporter assay, we showed that the elongated ALX4 displays increased activity. ALX4 negatively regulates the Wnt/β‐catenin pathway and accordingly, patient keratinocytes showed altered expression of genes associated with the WNT/β‐catenin pathway, which in turn may underlie ectodermal manifestations in FND2. In conclusion, dominant FND2 with ectodermal dysplasia results from frameshift variants in ALX4 exerting a gain‐of‐function effect.
- 19 September 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (12) , 2806-2812
Dominant frontonasal dysplasia with ectodermal defects results from increased activity of ALX4
Frontonasal dysplasia (FND) refers to a group of rare developmental disorders characterized by abnormal morphology of the craniofacial region. We studied a family manifesting with clinical features typical for FND2 including neurobehavioral abnormalities, hypotrichosis, hypodontia, and facial dysmorphism. Whole‐exome sequencing analysis identified a novel heterozygous frameshift insertion in ALX4 (c.985_986insGTGC, p.Pro329Argfs*115), encoding aristaless homeobox 4. This and a previously reported dominant FND2‐causing variant are predicted to result in the formation of a similar abnormally elongated protein tail domain. Using a reporter assay, we showed that the elongated ALX4 displays increased activity. ALX4 negatively regulates the Wnt/β‐catenin pathway and accordingly, patient keratinocytes showed altered expression of genes associated with the WNT/β‐catenin pathway, which in turn may underlie ectodermal manifestations in FND2. In conclusion, dominant FND2 with ectodermal dysplasia results from frameshift variants in ALX4 exerting a gain‐of‐function effect.
- Open Access
- 8 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (12) , 3192
Cutaneous and Developmental Effects of CARD14 Overexpression in Zebrafish
Background: Gain-of-function mutations in CARD14 have recently been shown to be involved in the pathogenesis of psoriasis and pityriasis rubra pilaris (PRP). Those mutations were found to activate the NF-kB signaling pathway. Objective: Zebrafish is often used to model human diseases in general, and in skin disorders more particularly. In the present study, we aimed to examine the effect of CARD14 overexpression in zebrafish with the aim to validate this model for future translational applications. Methods: We used light microscopy, scanning electron microscopy, histological analysis and whole mount in situ hybridization as well as real-time PCR to ascertain the effect of CARD14 overexpression in the developing zebrafish. Results: Overexpression of human CARD14 had a marked morphological and developmental effect on the embryos. Light microscopy demonstrated a characteristic cutaneous pattern including a granular surface and a spiky pigment pattern. In situ hybridization revealed keratinocytes of uneven size and shape. Scanning electron microscopy showed aberrant production of actin microridges and a rugged keratinocyte cell surface, reminiscent of the human hyperkeratotic phenotype. Developmentally, overexpression of CARD14 had a variable effect on anterior-posterior axis symmetry. Similar to what has been observed in humans with psoriasis or PRP, NF-kB expression was higher in CARD14-overexpressing embryos compared to controls. Conclusions: Overexpression of CARD14 results in a distinct cutaneous pattern accompanied by hyperactivation of the NF-kB pathway, suggesting that the zebrafish represents a useful system to model CARD14-associated papulosquamous diseases.
- 8 December 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (12) , 3192
Open AccessCutaneous and Developmental Effects of CARD14 Overexpression in Zebrafish
Background: Gain-of-function mutations in CARD14 have recently been shown to be involved in the pathogenesis of psoriasis and pityriasis rubra pilaris (PRP). Those mutations were found to activate the NF-kB signaling pathway. Objective: Zebrafish is often used to model human diseases in general, and in skin disorders more particularly. In the present study, we aimed to examine the effect of CARD14 overexpression in zebrafish with the aim to validate this model for future translational applications. Methods: We used light microscopy, scanning electron microscopy, histological analysis and whole mount in situ hybridization as well as real-time PCR to ascertain the effect of CARD14 overexpression in the developing zebrafish. Results: Overexpression of human CARD14 had a marked morphological and developmental effect on the embryos. Light microscopy demonstrated a characteristic cutaneous pattern including a granular surface and a spiky pigment pattern. In situ hybridization revealed keratinocytes of uneven size and shape. Scanning electron microscopy showed aberrant production of actin microridges and a rugged keratinocyte cell surface, reminiscent of the human hyperkeratotic phenotype. Developmentally, overexpression of CARD14 had a variable effect on anterior-posterior axis symmetry. Similar to what has been observed in humans with psoriasis or PRP, NF-kB expression was higher in CARD14-overexpressing embryos compared to controls. Conclusions: Overexpression of CARD14 results in a distinct cutaneous pattern accompanied by hyperactivation of the NF-kB pathway, suggesting that the zebrafish represents a useful system to model CARD14-associated papulosquamous diseases.
- 1 November 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (5) , 826-828
Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophy
- 1 November 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (5) , 826-828
Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophy
- 1 November 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (5) , 773-777
A unique skin phenotype resulting from a large heterozygous deletion spanning six keratin genes
The phenotypic spectrum of genodermatoses is continuously expanding. Three siblings were referred because of a highly unusual phenotype comprising alopecia, dystrophic nails, palmoplantar keratoderma and trauma-induced skin blistering. Whole-exome sequencing analysis identified a heterozygous large genomic alteration of around 116 0000 bp resulting in the deletion of the KRT9, KRT14, KRT15, KRT16 and KRT19 genes, as well as part of KRT17. This genomic change leads to the generation of a truncated keratin 17 (KRT17) protein encoded by the first three exons of the gene and part of intron 3. The three patients were found to carry the heterozygous genomic deletion while their healthy parents did not, indicative of germline mosaicism. The genomic alteration was found to result in reduced KRT17 expression in patient skin. More importantly, the abnormal truncated KRT17 was found to exert a deleterious effect on keratinocyte cytoskeleton formation, leading to keratin aggregation. Coexpression of wildtype and truncated KRT17 proteins also caused keratin aggregation, demonstrating that the deletion exerts a dominant negative effect. In conclusion, we are reporting on a novel clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes, thus expanding the spectrum of clinical manifestations associated with keratin disorders. What is already known about this topic? Various conditions known as keratinopathies have been shown over recent years to be associated with dominant or recessive variants in several individual keratin genes. What does this study add? We report three patients presenting with a unique clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes.The genomic variant is predicted to result in a truncated form of keratin 17, which was found in an in vitro assay to disrupt keratinocyte cell cytoskeleton formation.
- 1 November 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (5) , 773-777
A unique skin phenotype resulting from a large heterozygous deletion spanning six keratin genes
The phenotypic spectrum of genodermatoses is continuously expanding. Three siblings were referred because of a highly unusual phenotype comprising alopecia, dystrophic nails, palmoplantar keratoderma and trauma-induced skin blistering. Whole-exome sequencing analysis identified a heterozygous large genomic alteration of around 116 0000 bp resulting in the deletion of the KRT9, KRT14, KRT15, KRT16 and KRT19 genes, as well as part of KRT17. This genomic change leads to the generation of a truncated keratin 17 (KRT17) protein encoded by the first three exons of the gene and part of intron 3. The three patients were found to carry the heterozygous genomic deletion while their healthy parents did not, indicative of germline mosaicism. The genomic alteration was found to result in reduced KRT17 expression in patient skin. More importantly, the abnormal truncated KRT17 was found to exert a deleterious effect on keratinocyte cytoskeleton formation, leading to keratin aggregation. Coexpression of wildtype and truncated KRT17 proteins also caused keratin aggregation, demonstrating that the deletion exerts a dominant negative effect. In conclusion, we are reporting on a novel clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes, thus expanding the spectrum of clinical manifestations associated with keratin disorders. What is already known about this topic? Various conditions known as keratinopathies have been shown over recent years to be associated with dominant or recessive variants in several individual keratin genes. What does this study add? We report three patients presenting with a unique clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes.The genomic variant is predicted to result in a truncated form of keratin 17, which was found in an in vitro assay to disrupt keratinocyte cell cytoskeleton formation.
- 23 September 2022
- Published by Morressier GmbH
ESDR261 - A novel skin phenotype resulting from heterozygous deletion of six keratin genes
The phenotypic spectrum of genodermatoses is continuously expanding. Three individuals were referred because of a highly unusual phenotype compri | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR261 - A novel skin phenotype resulting from heterozygous deletion of six keratin genes
The phenotypic spectrum of genodermatoses is continuously expanding. Three individuals were referred because of a highly unusual phenotype compri | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR276 - CLDN1 is associated with autosomal recessive congenital ichthyosis
Autosomal recessive congenital recessive (ARCI) refers to a large and genetically heterogeneous group of non-syndromic disorders of cornification | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR276 - CLDN1 is associated with autosomal recessive congenital ichthyosis
Autosomal recessive congenital recessive (ARCI) refers to a large and genetically heterogeneous group of non-syndromic disorders of cornification | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR259 - KLF4 variants: a novel cause of palmoplantar keratoderma
A steadily growing number of hereditary palmoplantar keratodermas (PPKs) have been found to result from defective function of epidermal adhesion | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR259 - KLF4 variants: a novel cause of palmoplantar keratoderma
A steadily growing number of hereditary palmoplantar keratodermas (PPKs) have been found to result from defective function of epidermal adhesion | POSTER